Spectator on facebook

Spectator on facebook

CORPORATE BRIEFS

Slovakofarma reports net earnings of 224 million Sk at end of 3Q98

Slovakofarma Hlohovec, Slovakia's biggest pharmaceuticals producer, earned a net consolidated profit of 224 million Sk ($6.2 million) over nine months of this year, which is 53 million Sk up on net profit for 1H98. Before-tax profits were 399 million Sk ($11.08 million) on sales of 3.591 billion Sk ($100 million).

Slovakofarma's net profit last year was 344 million Sk, down 169 million Sk from 1996. Sales in 1997 were 4.57 billion Sk. The company's commercial plan for 1998 counts on consolidated sales of 5.5 billion Sk, and consolidated earnings are planned at 550 million Sk. Investments, including leasing, are to swallow up to 400 million Sk.

Slovakofarma is the largest, oldest, and most important pharmaceuticals company in Slovakia, and its domestic market share is 15%. It is one of the six largest pharmaceuticals companies in central and eastern Europe.

The processing of personal data is subject to our Privacy Policy and the Cookie Policy. Before submitting your e-mail address, please make sure to acquaint yourself with these documents.

Top stories

Slovak women scientists prove that science is not just for men

I grew up with the conviction that science belongs to men, said one awarded Slovak scientist.

Mariana Derzsi and Andrea Straková Fedorková

Five years after the Moldava raid, the victims have turned into perpetrators

June 19 marks the fifth anniversary of the brutal and much-discussed raid in the Roma settlement; and it points to five of those beaten being charged with perjury.

Moldava nad Bodvou

The UK is not cutting off its own hand, it is holding it out

It is not rational to behave towards the UK as if it posed a security risk to the EU.

Illustrative stock photo

Welcome to Slovakia?

Following Henry Acorda’s horrific killing, businesses need to stand up.

June 8 gathering in Bratislava